Unichem Laboratories Limited (BOM:506690)
357.50
-4.15 (-1.15%)
At close: May 26, 2026
Unichem Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 2,528 | 1,375 | -937.6 | -2,022 | 330.62 |
Depreciation & Amortization | 1,251 | 1,246 | 1,232 | 1,134 | 911.05 |
Other Amortization | - | - | - | 0.72 | 1.24 |
Loss (Gain) From Sale of Assets | -2,763 | -9.5 | -48.6 | -12.83 | 2.34 |
Asset Writedown & Restructuring Costs | 32.9 | - | - | - | - |
Loss (Gain) From Sale of Investments | -23.4 | 6.6 | -712.2 | -40.27 | 17.49 |
Loss (Gain) on Equity Investments | - | - | - | - | 10.61 |
Stock-Based Compensation | 8.1 | 21.2 | 30.8 | 10.49 | 28.48 |
Provision & Write-off of Bad Debts | -6.9 | 14.1 | 6.4 | 8.92 | -2.21 |
Other Operating Activities | 1,090 | 215.5 | 1,490 | 364.23 | -351.47 |
Change in Accounts Receivable | -208.8 | -390.4 | -53.9 | -1,236 | -2,771 |
Change in Inventory | 137.7 | -2,525 | -794.5 | -250.08 | -618.82 |
Change in Accounts Payable | -2,010 | -23.7 | -71.5 | 1,193 | -154.48 |
Operating Cash Flow | 36.4 | -70.2 | 140 | -850.91 | -2,596 |
Capital Expenditures | -1,230 | -1,374 | -225.5 | -443.16 | -1,270 |
Sale of Property, Plant & Equipment | 2,826 | 21.7 | 89.5 | 63.74 | 1.64 |
Divestitures | 40 | - | - | - | - |
Investment in Securities | - | 13.6 | 652.3 | 2,365 | 2,041 |
Other Investing Activities | 284.6 | -1,074 | -12.3 | 42.45 | 251.49 |
Investing Cash Flow | 1,921 | -2,412 | 504 | 2,028 | 1,024 |
Short-Term Debt Issued | 753.3 | 1,848 | - | - | 1,148 |
Long-Term Debt Issued | - | 503.9 | - | - | 1,242 |
Total Debt Issued | 753.3 | 2,352 | - | - | 2,390 |
Short-Term Debt Repaid | - | - | -528.2 | -76.93 | - |
Long-Term Debt Repaid | -481.7 | -315.6 | -310.5 | -290.63 | -143.65 |
Total Debt Repaid | -481.7 | -315.6 | -838.7 | -367.56 | -143.65 |
Net Debt Issued (Repaid) | 271.6 | 2,037 | -838.7 | -367.56 | 2,247 |
Common Dividends Paid | -3.7 | -3.4 | -2.1 | -282.55 | -283.62 |
Other Financing Activities | -249.3 | -195.7 | -222.3 | -162.9 | -50.82 |
Financing Cash Flow | 18.6 | 1,838 | -1,063 | -813 | 1,912 |
Miscellaneous Cash Flow Adjustments | 23.4 | -6.8 | 129.1 | 381.33 | -22.78 |
Net Cash Flow | 1,999 | -651.7 | -290 | 745.56 | 317.36 |
Free Cash Flow | -1,194 | -1,444 | -85.5 | -1,294 | -3,866 |
Free Cash Flow Margin | -5.27% | -6.84% | -0.48% | -9.63% | -30.45% |
Free Cash Flow Per Share | -16.93 | -20.44 | -1.21 | -18.38 | -54.78 |
Cash Interest Paid | - | 195.7 | 222.3 | 162.9 | 50.82 |
Cash Income Tax Paid | - | 164.2 | 63.7 | 122.11 | 76.15 |
Levered Free Cash Flow | -684.95 | -2,257 | 349.42 | -740.49 | -3,495 |
Unlevered Free Cash Flow | -487.51 | -2,127 | 487.86 | -638.92 | -3,463 |
Change in Working Capital | -2,081 | -2,939 | -919.9 | -293.61 | -3,544 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.